top of page
Search


Jun 14, 20234 min read
Recce Pharmaceuticals – working on the global health challenge of sepsis and superbugs
In 2020 The World Health Organization (WHO) released its first report on the global epidemiology and burden of sepsis. The report...
331 views0 comments


Apr 15, 20214 min read
Antisense Therapeutics Shares up 40% in a month. Strong Volume in Europe.
European investors have shown strong interest in Antisense Therapeutics Limited (ASX: ANP: FWB: AWY) since the company was dual listed in...
526 views0 comments


Mar 10, 20217 min read
Major global trends driving biotech investment in 2021
Platform technology Using mRNA as a medicine is a radically different approach than treating disease with other drug classes. mRNA is the...
2,325 views0 comments


Mar 8, 20213 min read
A global biotech leader in synthetic anti-infectives dual lists in Germany
Recce Pharmaceuticals Ltd (ASX: RCE) and (FSE: R9Q) is pioneering a new class of synthetic anti-infectives to address the urgent global...
425 views0 comments


Jan 8, 20212 min read
Antisense shares have increased by 60% after Sarepta results
Antisense Therapeutics (ASX: ANP) and (FRA: AWY) are up over 60% in 2 months. 2 major reasons for this: Sarpeta Therapeutics announced...
1,000 views0 comments


Dec 16, 20204 min read
Immutep Limited - a global leader in development of immunotherapy for cancer & autoimmune diseases
Immutep (ASX: IMM) and (FRA: YP1B) are the global leaders in understanding and development of therapeutics that modulate Lymphocyte...
85 views0 comments


Nov 27, 20203 min read
Australian biotech companies becoming global players
Australia has ranked in the top five globally for biotechnology three years running, outperforming nations such as the United Kingdom and...
93 views0 comments
bottom of page